Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.

Diseases

Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Amyotrophic lateral sclerosis type 5


Other Names for this Disease

  • ALS5
  • Amyotrophic lateral sclerosis 5
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.

Treatment

Management Guidelines

  • Orphanet Emergency Guidelines is an article which is expert-authored and peer-reviewed that is intended to guide health care professionals in emergency situations involving this condition.  

Medical Products

The medication(s) listed in the table(s) below have been approved by the Food and Drug Administration (FDA) for treatment of this condition. The FDA Office of Orphan Products Development designates "orphan products" for those that treat rare diseases affecting fewer than 200,000 Americans. The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products. To search for all FDA approved drugs, visit Drugs@FDA. You can find orphan products used to treat other conditions by searching the Orphan Drug Product Designation database.


Generic Name Riluzole
Trade Name
(Manufacturer Name)
Rilutek®
(Sanofi Aventis)
Indication
The FDA has approved this product to be used in this manner.
Treatment of patients with amyotrophic lateral sclerosis. Riluzole extends survival and/or time to tracheostomy.
More Information about this product Drug Information Portal
Medline Plus Health Information

Other Names for this Disease
  • ALS5
  • Amyotrophic lateral sclerosis 5
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.